About
Teva Pharmaceutical Industries Ltd (TA:TEVA) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 15 2026
Teva Launches Home Ground™ Schizophrenia Community, a New Online Resource Hub for People Living with Schizophrenia and Their Care Partners
Apr 14 2026
Community Routes: Access to Mental Health Care Provides Continued Funding for Mental Health Services at Free & Charitable Clinics
Mar 30 2026
Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)
Mar 19 2026
Teva Releases Q1 2026 Aide Memoire
Mar 19 2026
Teva to Host Conference Call to Discuss First Quarter 2026 Financial Results at 8 a.m. ET on April 29, 2026
Financials
Revenue
ILA17.26 B
Market Cap
ILA1.09 B
P/E Ratio
24.55
EPS
3.80
Google Übersetzer